Greg J Divis - Net Worth and Insider Trading
Greg J Divis Net Worth
The estimated net worth of Greg J Divis is at least $2 Million dollars as of 2024-12-01. Greg J Divis is the CEO of Avadel Pharmaceuticals PLC and owns about 159,100 shares of Avadel Pharmaceuticals PLC (AVDL) stock worth over $2 Million. Details can be seen in Greg J Divis's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Greg J Divis has not made any transactions after 2023-08-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Greg J Divis
Greg J Divis Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Greg J Divis owns 2 companies in total, including Avadel Pharmaceuticals PLC (AVDL) , and Jaguar Health Inc (JAGX) .
Click here to see the complete history of Greg J Divis’s form 4 insider trades.
Insider Ownership Summary of Greg J Divis
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVDL | Avadel Pharmaceuticals PLC | 2023-08-10 | director & Chief Executive Officer |
| JAGX | Jaguar Health Inc | 2018-06-14 | director |
Greg J Divis Latest Holdings Summary
Greg J Divis currently owns a total of 1 stock. Greg J Divis owns 159,100 shares of Avadel Pharmaceuticals PLC (AVDL) as of August 10, 2023, with a value of $2 Million.
Latest Holdings of Greg J Divis
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AVDL | Avadel Pharmaceuticals PLC | 2023-08-10 | 159,100 | 11.06 | 1,759,646 |
Holding Weightings of Greg J Divis
Greg J Divis Form 4 Trading Tracker
According to the SEC Form 4 filings, Greg J Divis has made a total of 3 transactions in Avadel Pharmaceuticals PLC (AVDL) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Avadel Pharmaceuticals PLC is the acquisition of 10,000 shares on August 10, 2023, which cost Greg J Divis around $132,000.
Insider Trading History of Greg J Divis
- 1
Greg J Divis Trading Performance
GuruFocus tracks the stock performance after each of Greg J Divis's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Greg J Divis is 22.19%. GuruFocus also compares Greg J Divis's trading performance to market benchmark return within the same time period. The performance of stocks bought by Greg J Divis within 3 months outperforms 2 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Greg J Divis's insider trading performs compared to the benchmark.
Performance of Greg J Divis
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.59 | | | | | |
| Relative Return to S&P 500(%) | 3.54 | | | | | |
Greg J Divis Ownership Network
Greg J Divis Owned Company Details
What does Avadel Pharmaceuticals PLC do?
Who are the key executives at Avadel Pharmaceuticals PLC?
Greg J Divis is the director & Chief Executive Officer of Avadel Pharmaceuticals PLC. Other key executives at Avadel Pharmaceuticals PLC include Chief Financial Officer Thomas S Mchugh , Chief Commercial Officer Richard J Kim , and Chief Medical Officer Douglas J Williamson .
Avadel Pharmaceuticals PLC (AVDL) Insider Trades Summary
Over the past 18 months, Greg J Divis made 1 insider transaction in Avadel Pharmaceuticals PLC (AVDL) with a net purchase of 10,000. Other recent insider transactions involving Avadel Pharmaceuticals PLC (AVDL) include a net sale of 103,975 shares made by Mark Anthony Mccamish , a net purchase of 4,000 shares made by Thomas S Mchugh , and a net purchase of 14,000 shares made by Geoffrey Michael Glass .
In summary, during the past 3 months, insiders sold 0 shares of Avadel Pharmaceuticals PLC (AVDL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 103,975 shares of Avadel Pharmaceuticals PLC (AVDL) were sold and 28,000 shares were bought by its insiders, resulting in a net sale of 75,975 shares.
Avadel Pharmaceuticals PLC (AVDL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avadel Pharmaceuticals PLC Insider Transactions
Greg J Divis Mailing Address
Above is the net worth, insider trading, and ownership report for Greg J Divis. You might contact Greg J Divis via mailing address: 10-1 Blanchardstown Corporate Park, Ballycoolin, Dublin L2 15.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
